Serum GIHCG accurately discriminated between RCC patients and HCs, as well as between early stage RCC patients and HCs. Positively correlation of increased GIHCG expression with advanced clinical stage, Fuhrman grade, and poor prognosis. This evidence concerns the gene GIHCG and renal cell carcinoma.